BU Researchers Find a Blood Marker That Could Help Detect CTE in Living Patients

A Boston University study in JAMA found a blood protein elevated in former football players with advanced CTE, a step toward a test in living people.

Share this article

Featured photo: Boston University School of Medicine’s Instructional Building in the South End, January 2012 (file photo). Photo: John Phelan, Wikimedia Commons, CC BY 3.0.

Researchers at Boston University have found a protein in blood that was much higher in people with advanced chronic traumatic encephalopathy, a step toward diagnosing the brain disease in living patients. Until now, CTE has been confirmed only after death.[1][2]

The study, published Thursday, Nov. 19, in JAMA, was led by BU’s CTE Center with Banner Health.[1][2] The protein is called eMTBR-tau.[1][2]

Advertisement
21
Former football players studied
18
Found to have CTE at autopsy
16
With high-stage CTE
~5 years
Possible time to FDA approval, per a lead researcher

Related: More Boston news: Boston Judge Strikes Down Trump’s HIV Funding Limits.

How the study worked

Researchers analyzed blood drawn from 21 former football players during their lives: 12 professionals, seven college players and two high school players. All later donated their brains to the BU CTE Center’s brain bank.[2] Autopsies found CTE in 18, including 16 with high-stage disease and two with low-stage disease. Three did not have CTE.[1][2]

The marker was not elevated in people with low-stage CTE or no CTE, so for now the results apply mainly to advanced disease.[2]

Telling CTE from Alzheimer’s

Five participants had both CTE and Alzheimer’s disease, and their eMTBR-tau levels were the highest. A common Alzheimer’s blood marker, p-tau217, was elevated only in people with Alzheimer’s, which suggests the two diseases might someday be told apart with a blood test.[1][2] A separate team in the same issue of JAMA also found the protein elevated in confirmed CTE cases.[2]

Advertisement

Not ready yet

The test is not approved by the FDA or available to the public. The study was small, included few low-stage cases and lacked age-matched controls.[2] Michael Alosco, a co-director of clinical research at the BU CTE Center, estimated approval could come in about five years if the findings hold up.[1] “This is a really exciting step, and it is a big breakthrough,” he said.[1]

The research was funded by the National Institutes of Health.[2] WBUR is licensed to Boston University.[1] More from Boston: BC will retire Johnny Gaudreau’s No. 13.

Sources

  1. WBUR: Boston University study points toward a potential blood test for CTE (Nov. 19, 2026)
  2. Boston 25 News: Boston University researchers say blood test could help detect CTE in living patients (Nov. 19, 2026)

About the reporter: Theo Lin is an AI reporter covering AI, technology and science for The Boston Report. This article was produced with AI under our editorial policy. Read our AI and media disclosure.

Read next in Boston Local News

Get The Boston Report Briefing

Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.

Free. We never sell your address. Privacy policy

Get The Boston Report Briefing
Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.
Sign up